Overview

Syringes and Cannulas Market Introduction Syringes and cannulas market is envisioned to value over US$ 24.5 Billion by 2029 end and register a CAGR of over 4% from 2020 to 2029. Syringes and cannulas are medical instruments which are mostly used for extraction of fluids from the body and performing surgeries. Syringes consist of a needle and hollow cylinder which is attached to a sliding plunger, whereas cannula consists of a retractable inner alongside a thin hollow tube. Global Syringes and Cannulas Market Overview

The rising number of incidences of chronic diseases like HIV and chronic diseases have propelled the growth of the market. The essentiality and easy accessibility of syringes and cannulas have led to the emergence of prefilled syringes and efficient alternatives, which has expanded the growth of the market. The market is bifurcated on product type and end-users. Product type consists of syringes and cannulas. The emergence of prefilled syringes is expected to boost the growth of the market in the coming time. Innovations in medical technology have led to manufacturers investing in R&D to provide new drug delivery solutions. For example, BD received FDA consent for the first syringe of Humulin®R U-500 insulin in 2016. Huge investments on disposable syringes are also fueling the growth of the market. Disposable syringes are expected to witness huge demand in future. An initiative like NPS has complemented the growth of the market.

Based on end-users, the market is divided into hospitals, diagnostic laboratories, clinics, nursing facilities, and others. Hospitals are expected to dominate the market during the forecast period. Hospital is the first place of treatment in every country. Easy to access and availability of the latest advanced technologies remain the biggest factor behind the growth of the hospital. Clinics are also expected to complement the growth of the market during the forecast period. A gradual increase in growth of the clinics in North America is expected to expand the size of the market. Based on regions, North America holds the majority share of the market. The presence of prominent players alongside developed healthcare infrastructure remains the key factor behind the growth of the market in the region. Asia-Pacific is the most lucrative region. India and China are expected to be the manufacturing hub of syringes. India, in particular, is witnessing rapid sales of syringes. A group of domestic manufacturers has announced voluntary deduction of the syringes, such a move is expected to fuel the growth of the market in the region. Established players of the market are Lifesciences Corporation, Medtronic Plc., Becton, Edwards Lifesciences Corporation, B.Braun Melsungen AG and others. Syringes and Cannulas Market Segmentation

By Product Type

• Syringes

• Cannulas By End Users

• Hospitals

• Diagnostic Laboratories

• Clinics

• Nursing Facilities

• Others By Region

• Europe

• North America

• APAC

• Latin America

• Rest of World Competitive Landscape:

• Tier 1 players- established companies in the market with a major market share

• Tier 2 players

• Emerging players which are growing rapidly

• New Entrants FutureWise Takeaways:

• Growth prospects

• SWOT analysis

• Key trends

• Key data points affecting market growth Objectives of the Study:

• To provide with an exhaustive analysis on the syringes and cannulas market based on the product type, end user, and region

• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)

• To evaluate and forecast micro-markets and the overall market

• To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East

• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions

• Profiling of companies to evaluate their market shares, strategies, financials and core competencies Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement

The customization services offered are free of charge with purchase of any license of the report.

You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com